Status:

COMPLETED

A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD

Lead Sponsor:

McMaster University

Collaborating Sponsors:

St. Joseph's Healthcare Hamilton

Conditions:

Gastroesophageal Reflux

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

LNF is an effective intervention in the management of patients with chronic GERD requiring maintenance therapy. LNF is cost-effective compared with long-term medical therapy. LNF is more effective th...

Detailed Description

GERD encompasses a variety of symptoms and pathological findings caused by the reflux of gastric contents into the esophagus although symptoms and pathology may occur independently of each other. GERD...

Eligibility Criteria

Inclusion

  • Male and female GERD patients aged 18-70 years with GERD symptoms.
  • Prior long-term treatment with PPI with minimum duration of 1 year with expected future duration of at least 2 more years.
  • Controlled on 20-40mg/day maintenance PPI therapy prior to study, defined as GERD symptom score\<18 and score of 70 or more on 1-100 Global Rating Scale at screening (on medication).
  • Increase in GERD symptom score\>=15 points at baseline (off omeprazole).
  • GERD symptom score\>=18 at baseline (off omeprazole).
  • Percent acid reflux in 24hr 4% at baseline (off omeprazole).
  • Positive Bernstein test at baseline.
  • Willingness to adhere to randomized treatment with availability for 3 years of follow-up.
  • Ability to answer self and interviewer-administered questions in English.
  • Signed informed consent.

Exclusion

  • Aperistaltic esophagus.
  • Severe cardiac, respiratory, hematologic or other disease constituting an unacceptable surgical risk in the investigator's opinion.
  • Previous gastric, esophageal or anti-reflux surgery.
  • History of malignancy within the last year with the exception of basal cell carcinoma.
  • Pregnancy or an intention to become pregnant in the following year.

Key Trial Info

Start Date :

January 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2010

Estimated Enrollment :

216 Patients enrolled

Trial Details

Trial ID

NCT00182260

Start Date

January 1 2000

End Date

April 1 2010

Last Update

November 15 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, Canada, L8N 4A6